Purchase Order 75N94021P00876
- Not listed
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services. The $22,080.00 contract has a period of performance ending on September 22, 2024. Metabolon has served as a prime contractor on numerous federal contracts, providing metabolic profiling of biological samples to support research initiatives across agencies such as the...
- This is a $24,300 firm fixed-price purchase order awarded by a civilian federal agency to Metabolon, Inc., a self-certified small disadvantaged business, for metabolite profile processing services. The contract has no set-aside designation and is scheduled for completion by November 30, 2020. Metabolon is a leading provider of specialized metabolomics services and solutions to various federal agencies, offering advanced analytical capabilities in metabolite identification and quantification. The...
- This firm fixed price purchase order contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Metabolon, Inc., a self-certified small disadvantaged business. The $124,800 contract is for a project titled "The Effect of Pre-Analytical Conditions on Metabolite Stability in Urine." Metabolon is a leading provider of metabolomics solutions and has served as both a prime contractor and subcontractor on...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business, for the cross-comparison of samples from pediatric patients with Smith-Lemli-Opitz syndrome (SLOS), Niemann-Pick disease (NPC), and Creatine Transporter Deficiency (CTD) using metabolomics analysis. The contract has a total value of $43,450.00 and a period of performance ending on August...
- This is a $40,500 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a study comparing patients with lipodystrophy to patients with insulin receptor mutations. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker...
- This is a $17,000 federal purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a small disadvantaged business, for metabolite analysis services. The contract is not set aside. Metabolon is a leading provider of metabolomics solutions that leverages proprietary technology to identify and quantify metabolites from biological samples. This contract supports NIDDK's research initiatives, such as the analysis of serum...
- This federal contract award is for a $28,172.64 firm fixed price purchase order issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for specialized metabolomics analysis services to support NIDDK research, specifically the development of a diagnostic test to monitor the progression of Type 1 Diabetes. Metabolon will leverage its proprietary UHPLC-MS/MS platform and statistical...
- This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
- The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), awarded a sole-source contract to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic analysis services. The $28,991.20 firm-fixed-price purchase order is to support the Liver Diseases Branch's research on microbiomes and their effects on host physiology and immune responses. Metabolon will use ultra-high performance liquid chromatography...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Metabolon, Inc., a self-certified small disadvantaged business, for other functions metabolic analyses of art samples. The potential value of the contract is $51,060.00, with a completion date of October 31, 2017. Metabolon is a leading provider of metabolomics solutions, offering analytical methods...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for the collection and analysis of 48 24-hour urine samples from a low-calorie-low-fat (LCLF) diet intervention study. Metabolon, a leading provider of metabolomics services, will leverage its proprietary analytical platforms to identify and quantify metabolites from the samples, providing insights that can support NICHD's research into disease processes and overall health status. This contract is not associated with a set-aside. Metabolon has extensive experience as both a prime contractor and subcontractor on numerous federal awards, delivering specialized metabolomics services to agencies like the VA, NIH, FDA, DoD, EPA, and USDA to support a wide range of research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 9/29/22 | |
| Not listed | Not listed | $15.0k | 9/14/21 |